Evidence map›Paper›PMID 31976858›Full record

ArticleeLife2020

A regulatory microRNA network controls endothelial cell phenotypic switch during sprouting angiogenesis.

Stefania Rosano, Davide Corà, Sushant Parab, Serena Zaffuto, Claudio Isella, Roberta Porporato, Roxana Maria Hoza, Raffaele A Calogero, Chiara Riganti, Federico Bussolino and 1 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
3.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Anti-angiogenic properties of microRNA-29a in preclinical ocular models.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  17. Angioregulatory microRNAs in breast cancerJournal of advanced research · 2022
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Stefania RosanoDepartment of Oncology, University of Turin, Candiolo, Italy.
Davide CoràDepartment of Translational Medicine, Piemonte Orientale University, Novara, Italy.
Sushant ParabDepartment of Oncology, University of Turin, Candiolo, Italy.
Serena ZaffutoDepartment of Oncology, University of Turin, Candiolo, Italy.
Claudio IsellaDepartment of Oncology, University of Turin, Candiolo, Italy.
Roberta PorporatoCandiolo Cancer Institute FPO-IRCCS, Candiolo, Italy.
Roxana Maria HozaDepartment of Oncology, University of Turin, Candiolo, Italy.
Raffaele A CalogeroMolecular Biotechnology Center, Department of Biotechnology and Health Sciences, University of Turin, Turin, Italy.
Chiara RigantiDepartment of Oncology, University of Turin, Candiolo, Italy.
Federico Bussolino *Department of Oncology, University of Turin, Candiolo, Italy.
Alessio Noghero *Department of Oncology, University of Turin, Candiolo, Italy.ORCID 0000-0002-8266-9247
Candiolo Cancer Institute · ITUniversità degli Studi del Piemonte Orientale “Amedeo Avogadro” · ITUniversity of Turin · IT

Funding

Associazione Italiana per la Ricerca sul Cancro 12182Associazione Italiana per la Ricerca sul Cancro 18652Associazione Italiana per la Ricerca sul Cancro 22910Ministero della Salute Era-net TRS-2018-00000689Ministero dell'Istruzione, dell'Università e della Ricerca FPRC 5xmille 2016 BiofilmMinistero dell'Istruzione, dell'Università e della Ricerca PRIN 2017, 2017237P5XRegione Piemonte A1907A Deflect
6 · The paper itself

Abstract

Angiogenesis requires the temporal coordination of the proliferation and the migration of endothelial cells. Here, we investigated the regulatory role of microRNAs (miRNAs) in harmonizing angiogenesis processes in a three-dimensional in vitro model. We described a microRNA network which contributes to the observed down- and upregulation of proliferative and migratory genes, respectively. Global analysis of miRNA-target gene interactions identified two sub-network modules, the first organized in upregulated miRNAs connected with downregulated target genes and the second with opposite features. miR-424-5p and miR-29a-3p were selected for the network validation. Gain- and loss-of-function approaches targeting these microRNAs impaired angiogenesis, suggesting that these modules are instrumental to the temporal coordination of endothelial migration and proliferation. Interestingly, miR-29a-3p and its targets belong to a selective biomarker that is able to identify colorectal cancer patients who are responding to anti-angiogenic treatments. Our results provide a view of higher-order interactions in angiogenesis that has potential to provide diagnostic and therapeutic insights.

Indexed as

Endothelial CellsMicroRNAsNeovascularization, PhysiologicAngiogenesis InhibitorsBiomarkers, TumorCells, CulturedColorectal NeoplasmsGene Expression Regulation, NeoplasticHumansHuman Umbilical Vein Endothelial CellsNeovascularization, PathologicPhenotypeAngiogenesis InhibitorsBiomarkers, TumorMicroRNAsangiogenesiscell biologycomputational biologyhumanmicroRNAnetworksystems biologyVEGF

Identifiers

PMID31976858
PMCPMC7299339
OpenAlexW3002224205

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.